Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):225-6

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

SPECIAL ARTICLE   

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):225-6

DOI: 10.23736/S1824-4785.19.03171-6

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

Two-way crossed cerebellar diaschisis in a clinically isolated syndrome suggestive of multiple sclerosis

Giacomo BOFFA 1, 2 , Caterina LAPUCCI 1, 2, Silvia D. MORBELLI 1, 2, Flavio M. NOBILI 1, 2

1 Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy; 2 San Martino Hospital and Institute for Cancer Research and Care, Genoa, Italy



The term diaschisis refers to a neural dysfunction manifesting in anatomically intact, but functionally related, brain regions distant from a primary lesion. Here we report the diaschisis phenomenon as a consequence of a first demyelinating event in the middle and superior cerebellar peduncles in both the ipsilateral cerebellar hemisphere and in the contralateral thalamus and cerebral cortex (two-way crossed cerebellar diaschisis), resulting in the simultaneous disruption of the afferent cortico-ponto-cerebellar pathway and the efferent cerebellar-thalamo-cortical pathway. The use of 18F-FDG-PET could help clarifying in vivo the distant pathophysiological effect of focal lesions in inflammatory diseases such as multiple sclerosis.


KEY WORDS: Brain injuries; Fluorodeoxyglucose F18; Multiple sclerosis

inizio pagina